Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Significance: Since the first reports of atypical femoral fractures (AFFs), a clinical phenomenon in which patients experience catastrophic brittle fractures of the femoral shaft with minimal trauma, the risk associated with bisphosphonates, the most widely prescribed pharmaceuticals for osteoporosis, has become increasingly well-established. However, the underlying cause of AFFs and their causal relationship to bisphosphonates is unknown. Here we examine bone tissue from women with AFFs and show that long-term bisphosphonate treatment degrades the fracture-resistance toughening mechanisms that are inherent to healthy bone. Our work resolves the apparent paradox of AFFs as a side effect of the most common osteoporosis treatment by clarifying the differing effects of bisphosphonates on bone tissue structure and mechanical properties across multiple length scales.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and there is concern that long-term use of antiresorptive therapies can result in decreased toughness (48, 72, 73).”
From Bone Mechanical Properties in Healthy and Diseased States (2018) · cites this paper as [48]
The cited source says what the claim attributes to it.
In the citing paper
“However, increased mineral content, such as that which can occur with long-term bisphosphonate therapy for treatment of osteoporosis, is associated with decreased fracture toughness (48).”
From Bone Mechanical Properties in Healthy and Diseased States (2018) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oliver, W. C., & Pharr, G. M. (1992) · Journal of Materials Research · doi:10.1557/jmr.1992.1564 · Cited by 26,961 · cited 1×
“The unloading curve of each indent was analyzed to find the hardness and reduced modulus (39).”
MethodBlack, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Harris, S. T. (1999) · JAMA · doi:10.1001/jama.282.14.1344 · Cited by 2,475 · cited 1×
“Bisphosphonates minimize bone loss and reduce the risk of fracture in patients with postmenopausal osteoporosis (4, 5).”
BackgroundCummings, S. R. (1998) · JAMA · doi:10.1001/jama.280.24.2077 · Cited by 2,277 · cited 2×
“Prior studies examining the mechanical properties of bisphosphonate-treated bone have focused primarily on the role of turnover suppression in preventing bone loss at cancellous sites of typical osteoporotic fractures (4, 11, 12).”
BackgroundShane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147 · cited 2×
“The subtrochanteric cortical site and transverse morphology characteristic of a brittle fracture contrast with the cancellous site and intertrochanteric or femoral neck morphologies observed in typical fragility fractures at the hip (6, 7) (Fig.”
BackgroundSelf-citationSeverely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy
Odvina, C. V., Zerwekh, J. E., Rao, D. S., Maalouf, N., Gottschalk, F. A., & Pak, C. Y. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0952 · Cited by 1,432 · cited 1×
“Since the first case reports of atypical fractures (20) many studies have addressed the epidemiology (21, 22), radiographic morphology (23, 24), and clinical management of atypical fractures (summarized in refs.”
BackgroundShane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116
Self-citationSpecific proteins mediate enhanced osteoblast adhesion on nanophase ceramics
Webster, T. J., Ergun, C., Doremus, R. H., Siegel, R. W., & Bizios, R. (2000) · Journal of Biomedical Materials Research · doi:10.1002/1097-4636(20000905)51:3<299::aid-jbm2>3.0.co;2-8 · Cited by 995
Bisphosphonates: mechanisms of action.
Rodan, G. A., & Fleisch, H. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118722 · Cited by 921
On the Mechanistic Origins of Toughness in Bone
Launey, M. E., Buehler, M. J., & Ritchie, R. O. (2010) · Annual Review of Materials Research · doi:10.1146/annurev-matsci-070909-104427 · Cited by 741 · cited 1×
“In contrast, AFFs occur in cortical bone and seem to propagate through a stress fracture-like mechanism, suggesting that by reducing turnover bisphosphonates may impair toughening mechanisms in cortical bone, which act as important barriers to clinical fracture in healthy bone (7, 13).”
BackgroundSelf-citationMechanistic fracture criteria for the failure of human cortical bone
Nalla, R. K., Kinney, J. H., & Ritchie, R. O. (2003) · Nature Materials · doi:10.1038/nmat832 · Cited by 730 · cited 2×
“In this study, analysis of tissue fracture toughness as a function of crack extension (R-curves) shows that bone tissue from patients treated with bisphosphonates has an overall decrease in the stress intensity required to propagate a crack, and decreased crackinitiation toughness, which indicates a deficit in intrins…”
BackgroundSelf-citationBisphosphonate Use and Atypical Fractures of the Femoral Shaft
Schilcher, J., Michaëlsson, K., & Aspenberg, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010650 · Cited by 695 · cited 3×
“Since the first reports of AFFs the risk associated with long-term bisphosphonate treatment has become increasingly well-established (21, 22).”
BackgroundAdler, R. A., El-Hajj Fuleihan, G., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J., Favus, M. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2708 · Cited by 672
The true toughness of human cortical bone measured with realistically short cracks
Koester, K. J., Ager, J. W., & Ritchie, R. O. (2008) · Nature Materials · doi:10.1038/nmat2221 · Cited by 558 · cited 1×
“Crack splitting, deflection, and twist are extrinsic toughening mechanisms that consume energy that would otherwise be used to propagate the crack forward, thereby decreasing the local stress intensity actually experienced at the crack tip, essentially doubling the fracture toughness of cortical bone (26, 30).”
BackgroundSelf-citationThe molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs
Kavanagh, K. L., Guo, K., Dunford, J. E., Wu, X., Knapp, S., Ebetino, F. H., Rogers, M. J., Russell, R. G. G., & Oppermann, U. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601643103 · Cited by 536
Low-Energy Femoral Shaft Fractures Associated With Alendronate Use
Neviaser, A. S., Lane, J. M., Lenart, B. A., Edobor-Osula, F., & Lorich, D. G. (2008) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0b013e318172841c · Cited by 526 · cited 2×
“Clinically, AFFs often occur with prodromal pain and form a stress callus, indicating that they are likely stress fractures caused by fatigue loading (23, 24).”
BackgroundSelf-citationBisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
Black, D. M., Kelly, M. P., Genant, H. K., Palermo, L., Eastell, R., Bucci-Rechtweg, C., Cauley, J., Leung, P. C., Boonen, S., Santora, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001086 · Cited by 512
Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate
Lenart, B. A., Lorich, D. G., & Lane, J. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0707493 · Cited by 498 · cited 2×
“Clinically, AFFs often occur with prodromal pain and form a stress callus, indicating that they are likely stress fractures caused by fatigue loading (23, 24).”
BackgroundSelf-citationAkkus, O., Adar, F., & Schaffler, M. B. (2004) · Bone · doi:10.1016/j.bone.2003.11.003 · Cited by 447
Nanoscale heterogeneity promotes energy dissipation in bone
Tai, K., Dao, M., Suresh, S., Palazoglu, A., & Ortiz, C. (2007) · Nature Materials · doi:10.1038/nmat1911 · Cited by 402 · cited 2×
“the intrinsic plasticity that nanoscale heterogeneity provides (17, 18); and by increasing nonenzymatic collagen cross-linking, which may lead to loss of postyield (intrinsic) toughness through reduced collagen fibrillar sliding (14, 19).”
BackgroundRoschger, P., Rinnerthaler, S., Yates, J., Rodan, G. A., Fratzl, P., & Klaushofer, K. (2001) · Bone · doi:10.1016/s8756-3282(01)00485-9 · Cited by 384 · cited 1×
“The observed greater mean mineralization in the cortices of patients treated with bisphosphonates is consistent with greater tissue maturity arising from reduced remodeling and consistent with previous studies showing changes in compositional properties of bone tissue from patients treated with bisphosphonates (17, 25…”
ResultAbrahamsen, B., Eiken, P., & Eastell, R. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081247 · Cited by 366
Hengsberger, S., Kulik, A., & Zysset, P. (2002) · Bone · doi:10.1016/s8756-3282(01)00624-x · Cited by 363 · cited 1×
“Although all nanoindentation tests used for nanoindentation analysis were performed on samples in a dehydrated state, previous literature suggests that sample drying and embedding would result in a linear increase in modulus of between 9 and 20% (43).”
MethodA Crisis in the Treatment of Osteoporosis
Khosla, S., & Shane, E. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2888 · Cited by 319
Burr, D. B., Schaffler, M. B., & Frederickson, R. G. (1988) · Journal of Biomechanics · doi:10.1016/0021-9290(88)90132-7 · Cited by 298 · cited 1×
“However, increased heterogeneity can also act as a stress riser, concentrating the stress intensity and decreasing bone fracture resistance (31).”
BackgroundFracture in human cortical bone: local fracture criteria and toughening mechanisms
Nalla, R. K., Stölken, J. S., Kinney, J. H., & Ritchie, R. O. (2005) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2004.07.010 · Cited by 260 · cited 1×
“In this study, analysis of tissue fracture toughness as a function of crack extension (R-curves) shows that bone tissue from patients treated with bisphosphonates has an overall decrease in the stress intensity required to propagate a crack, and decreased crackinitiation toughness, which indicates a deficit in intrins…”
BackgroundSelf-citationJha, S., Wang, Z., Laucis, N., & Bhattacharyya, T. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2565 · Cited by 230
Tang, S. Y., Allen, M. R., Phipps, R., Burr, D. B., & Vashishth, D. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0754-4 · Cited by 218 · cited 1×
“the intrinsic plasticity that nanoscale heterogeneity provides (17, 18); and by increasing nonenzymatic collagen cross-linking, which may lead to loss of postyield (intrinsic) toughness through reduced collagen fibrillar sliding (14, 19).”
BackgroundDonnelly, E., Meredith, D. S., Nguyen, J. T., Gladnick, B. P., Rebolledo, B. J., Shaffer, A. D., Lorich, D. G., Lane, J. M., & Boskey, A. L. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.560 · Cited by 211 · cited 4×
“The observed greater mean mineralization in the cortices of patients treated with bisphosphonates is consistent with greater tissue maturity arising from reduced remodeling and consistent with previous studies showing changes in compositional properties of bone tissue from patients treated with bisphosphonates (17, 25…”
BackgroundResultInfluentialSelf-citationDonnelly, E., Baker, S. P., Boskey, A. L., & van der Meulen, M. C. H. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30633 · Cited by 208
Self-citationUse of FTIR Spectroscopic Imaging to Identify Parameters Associated With Fragility Fracture
Gourion-Arsiquaud, S., Faibish, D., Myers, E., Spevak, L., Compston, J., Hodsman, A., Shane, E., Recker, R. R., Boskey, E. R., & Boskey, A. L. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090414 · Cited by 191 · cited 1×
“Consistent with these results, increased FTIR mineralization and collagen maturity are associated with increased fracture risk (29).”
ResultVitamin D Deficiency Induces Early Signs of Aging in Human Bone, Increasing the Risk of Fracture
Busse, B., Bale, H. A., Zimmermann, E. A., Panganiban, B., Barth, H. D., Carriero, A., Vettorazzi, E., Zustin, J., Hahn, M., Ager, J. W., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006286 · Cited by 171 · cited 1×
“contributes minimally to fracture toughness measurements of hydrated samples (40).”
BackgroundSelf-citationBisphosphonates for postmenopausal osteoporosis
Eastell, R., Walsh, J., Watts, N. B., & Siris, E. S. (2011) · Bone · doi:10.1016/j.bone.2011.02.011 · Cited by 148
Sasaki, S., Miyakoshi, N., Hongo, M., Kasukawa, Y., & Shimada, Y. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0358-0 · Cited by 143 · cited 1×
“Retrospective radiographic review demonstrated that patients with AFFs had greater femoral curvature than nonfracture controls, which would contribute to greater tensile stresses on the lateral cortices of the AFF patients (34).”
BackgroundZimmermann, E. A., Schaible, E. G., Gludovatz, B., Schmidt, F. N., Riedel, C., Krause, M., Vettorazzi, E., Acevedo, C., Hahn, M. P., Püschel, K., et al. (2016) · Scientific Reports · doi:10.1038/srep21072 · Cited by 124
Self-citationAdler, R. A., El-Hajj Fuleihan, G., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J., Favus, M. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2918 · Cited by 105
Yeni, Y. N., & Norman, T. L. (2000) · Journal of Biomedical Materials Research · doi:10.1002/1097-4636(20000905)51:3<504::aid-jbm27>3.0.co;2-i · Cited by 102
Boskey, A. L., Donnelly, E. L., Boskey, E. R., Spevak, L., Ma, Y., Zhang, W., Lappe, J. M., & Recker, R. R. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2759 · Cited by 97
Self-citationAcevedo, C., Bale, H., Gludovatz, B., Wat, A., Tang, S. Y., Wang, M., Busse, B., Zimmermann, E. A., Schaible, E. G., Allen, M. R., et al. (2015) · Bone · doi:10.1016/j.bone.2015.08.002 · Cited by 84 · cited 1×
“the intrinsic plasticity that nanoscale heterogeneity provides (17, 18); and by increasing nonenzymatic collagen cross-linking, which may lead to loss of postyield (intrinsic) toughness through reduced collagen fibrillar sliding (14, 19).”
BackgroundSelf-citationThe resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate
Bajaj, D., Geissler, J. R., Allen, M. R., Burr, D. B., & Fritton, J. C. (2014) · Bone · doi:10.1016/j.bone.2014.03.045 · Cited by 54
Bisphosphonates in preclinical bone oncology
Clézardin, P., Benzaïd, I., & Croucher, P. I. (2010) · Bone · doi:10.1016/j.bone.2010.11.017 · Cited by 52
La Rocca Vieira, R., Rosenberg, Z. S., Allison, M. B., Im, S. A., Babb, J., & Peck, V. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7442 · Cited by 49 · cited 1×
“The incidence of “incomplete” AFFs in asymptomatic patients is much higher than that of complete catastrophic atypical fractures (35), suggesting that the majority of patients who experience a partial AFF may recover through healing of the incomplete fracture before it propagates.”
BackgroundNotch sensitivity of mammalian mineralized tissues in impact
Currey, J. D., Brear, K., & Zioupos, P. (2004) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2003.2634 · Cited by 44 · cited 1×
“Cortical bone from patients with atypical fractures had greater tissue mineral content as assessed by Raman and FTIR imaging and greater collagen maturity as assessed by FTIR imaging, as well as greater hardness, relative to that from patients without fractures, all of which are expected to diminish the ductility and…”
Background
Cited by
Bone Mechanical Properties in Healthy and Diseased States
Morgan, E. F., Unnikrisnan, G. U., & Hussein, A. I. (2018) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121139 · Cited by 1,026
“However, increased mineral content, such as that which can occur with long-term bisphosphonate therapy for treatment of osteoporosis, is associated with decreased fracture toughness (48).”
Regulation of TNF-Induced Osteoclast Differentiation
Yao, Z., Getting, S. J., & Locke, I. C. (2021) · Cells · doi:10.3390/cells11010132 · Cited by 280
“Of concern is that bisphosphonates can result in atypical femoral fractures [16,17], hypocalcemia [18], and osteonecrosis of jaw bone [19,20] in a small number of patients.”
BackgroundEvenepoel, P., Cunningham, J., Ferrari, S., Haarhaus, M., Javaid, M. K., Lafage-Proust, M.-H., Prieto-Alhambra, D., Torres, P. U., Cannata-Andia, J., European Renal Osteodystrophy (EUROD) workgroup, A. I. O. T. C.-M. W. G. O. T. E.-E., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa192 · Cited by 207
“Furthermore, according to a recent bone biopsy study, overmineralization (often referred to as brit-tle bone) may impair toughening mechanisms in cortical bone, which in turn may confer an increased risk of atypical fractures [131].”
BackgroundBlack, D. M., Abrahamsen, B., Bouxsein, M. L., Einhorn, T., & Napoli, N. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00001 · Cited by 198
The Role of Matrix Composition in the Mechanical Behavior of Bone
Ünal, M., Creecy, A., & Nyman, J. S. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0433-0 · Cited by 168
Metadata
- Authors
- Lloyd, A. A., Gludovatz, B., Riedel, C., Luengo, E. A., Saiyed, R., Marty, E., Lorich, D. G., Lane, J. M., Ritchie, R. O., Busse, B., & Donnelly, E.
- Affiliations
- Cornell University (US)
- UNSW Sydney (AU)
- Universität Hamburg (DE)
- Hospital for Special Surgery (US)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Donnelly, Eve
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-07-31
- Volume
- 114
- Issue
- 33
- Pages
- 8722-8727
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5565436
- OpenAlex
- W2740936167
- Cited by
- 158
- References
- 42
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 10 · 2023: 10 · 2022: 16 · 2021: 24 · 2020: 33 · 2019: 21 · 2018: 24 · 2017: 2
- FWCI
- 24.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Science Foundation (NSF-CMMI 1452852, DGE-1144153, DMR-1120296)
- American Society for Bone and Mineral Research (Junior Faculty Osteoporosis Research Award 2012)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Keywords
- atypical femoral fractures, bisphosphonates, osteoporosis treatment, fracture resistance, bone mechanical properties, femoral diaphysis, women, bone microarchitecture, adverse drug reactions
- MeSH terms
- Aged, Aged, 80 and over, Diphosphonates, Female, Femur, Humans, Osteoporosis, Bone Density, Postmenopause, Bone Density Conservation Agents, Osteoporotic Fractures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.